Keystone Heart, Ltd. is a medical device company developing and manufacturing cerebral embolic protection (CEP) devices to reduce the risk of stroke, neurocognitive decline and dementia caused by brain emboli associated with cardiovascular procedures.

Keystone Heart is focused on protecting the brain from emboli to reduce the risk of brain infarcts during TAVR, surgical valve replacement, atrial fibrillation ablation and other structural heart procedures. Novel devices developed by Keystone Heart are designed to help interventional cardiologists and electrophysiologists protect the brain while performing these procedures. The TriGUARD 3™ Cerebral Embolic Protection Device is designed to cover all three major cerebral branches to minimize the risk of brain damage during cardiovascular procedures.

http://www.keystoneheart.com/eu/clinical-evidence/clinical-studies/